Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medgenics Inc Common Stock (MDGN)

Medgenics Inc Common Stock (MDGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medgenics Inc Common Stock C/O MEDGENICS INC. 435 DEVON PARK DRIVE BLDG 700 WAYNE PA 19087

www.medgenics.com P: 610-254-4201

Description:

Medgenics, Inc. is a medical technology and therapeutics company focused on providing sustained protein therapies. The Company's Biopump Platform Technology uses the patient's own tissue for the treatment of a range of chronic diseases. Its products include EPODURE focused on the treatment of chronic renal anemia and INFRADURE focused on the treatment of hepatitis C. Medgenics, Inc. is based in Vienna, Virginia.

Key Statistics

Overview:

Market Capitalization, $K 200,330
Shares Outstanding, K 37,080
Annual Sales, $ 0 K
Annual Net Income, $ -37,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,570 K
60-Month Beta 1.17
% of Insider Shareholders 23.40%
% of Institutional Shareholders 44.40%

Growth:

1-Year Return -8.39%
3-Year Return -5.91%
5-Year Return 121.91%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/03/16
Earnings Per Share ttm -1.23
EPS Growth vs. Prev Qtr 17.14%
EPS Growth vs. Prev Year 12.12%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MDGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -85.70%
Return-on-Assets % -78.57%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.82
Book Value/Share 1.16
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar